Real-World Outcomes of Selective RET Inhibitor Selpercatinib in the United States: Descriptive, Retrospective Findings from Two Databases †.

Autor: Liao, Chi-Yin1 (AUTHOR) chiyin.liao@lilly.com, Gonzalez-Ferrer, Carmen1 (AUTHOR), Whipple, Samuel1 (AUTHOR), Peterson, Patrick M.1 (AUTHOR), Barker, Scott S.1 (AUTHOR), Bhandari, Naleen Raj1 (AUTHOR), Wang, Feng1 (AUTHOR) peterfeng.wang@lilly.com
Zdroj: Cancers. Nov2024, Vol. 16 Issue 22, p3835. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje